APA patients with KCNJ5 mutations have been reported to be younger, have a higher aldosterone level, lower potassium level, and higher hypertension cure rate compared to those without mutations in previous studies [15,16,17,22]. Here, KCNJ5 is linked to hypertensive disorder.